Regenxbio Inc (RGNX)

Cost of Revenue

$1.04M

Quarterly · Period ending: · USD

RGNX logo

RGNX Cost of Revenue

Latest reported$1.04M
RGNX Quarterly Cost of Revenue ($1.48M → $1.04M)
High-resolution chart · PNG

RGNX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,042,000
11,074,000
5,928,000
61,826,000
9,114,000
3,436,000
6,318,000
12,387,000
14,630,000
8,463,000
15,573,000
12,388,000
9,475,000
4,112,000
12,783,000
13,094,000
12,951,000
15,717,000
23,058,000
14,105,000
9,819,000
4,851,000
10,257,000
17,364,000
4,684,000
3,409,000
3,791,000
2,494,000
1,927,000
29,000
2,843,000
517,000
3,872,000
2,408,000
13,788,000
683,000
1,317,000
91,000
330,000
35,000
498,000
96,000
883,000
257,000
310,000
53,000
151,000
12,000
1,148,000
1,482,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.